Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8609052rdf:typepubmed:Citationlld:pubmed
pubmed-article:8609052lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0221920lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0032144lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0332208lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0026559lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0018284lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8609052lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8609052pubmed:issue1lld:pubmed
pubmed-article:8609052pubmed:dateCreated1996-5-29lld:pubmed
pubmed-article:8609052pubmed:abstractTextEpidermal growth factor (EGF) or transforming growth factor-alpha (TGF-alpha) stimulates cell migration, proliferation and the formation of tube-like structures of human microvascular endothelial cells in culture. Heparin-binding EGF-like growth factor(HB-EGF), which shows 35% homology with EGF/TGF-alpha, is a member of the EGF family, and it is ubiquitous in many tissues and organs. We examined whether or not HB-EGF induced angiogenic responses in human microvascular endothelial cells. HB-EGF inhibited the binding of (125) I-EGF to the EGF receptor and induced autophosphorylation of the receptor on endothelial cells. Exogenous HB-EGF induced the loss of more than 70% of the EGF receptor from the cell surface within 30 min, with similar kinetics to that of EGF. The level of c-fos mRNA markedly increased at 30 min in response to HB-EGF as well as EGF. A gel shift assay demonstrated the activation of the transcription factor p91 by HB-EGF and EGF. This factor directly interacts with EGF receptor and mediates the activation of c-fos gene promoter. HB-EGF enhanced the mRNA expression of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) mRNA. However, the enhancement of t-PA and PAI-1 by HB-EGF was less than that by EGF. Heparitinase/chlorate, which digests the heparan sulfate proteoglycan of the endothelial cell surface, restored both t-PA and PAI-1 mRNA levels in response to HB-EGF in a manner similar to that by EGF. HB-EGF at 10 ng/ml developed tube-like structures in type I collagen gel at similar levels to that of EGF at 10 ng/ml, suggesting that HB-EGF is also a potent angiogenic factor in the model system for angiogenesis. The tubulogenesis activity of HB-EGF is discussed in relation to the expression of the t-PA and PAI-1 genes.lld:pubmed
pubmed-article:8609052pubmed:languageenglld:pubmed
pubmed-article:8609052pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:citationSubsetIMlld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8609052pubmed:statusMEDLINElld:pubmed
pubmed-article:8609052pubmed:monthJanlld:pubmed
pubmed-article:8609052pubmed:issn0910-5050lld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:OnoMMlld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:TaniguchiNNlld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:KuwanoMMlld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:KohnoKKlld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:IzumiHHlld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:UshiroSSlld:pubmed
pubmed-article:8609052pubmed:authorpubmed-author:HigashiyamaSSlld:pubmed
pubmed-article:8609052pubmed:issnTypePrintlld:pubmed
pubmed-article:8609052pubmed:volume87lld:pubmed
pubmed-article:8609052pubmed:ownerNLMlld:pubmed
pubmed-article:8609052pubmed:authorsCompleteYlld:pubmed
pubmed-article:8609052pubmed:pagination68-77lld:pubmed
pubmed-article:8609052pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:meshHeadingpubmed-meshheading:8609052-...lld:pubmed
pubmed-article:8609052pubmed:year1996lld:pubmed
pubmed-article:8609052pubmed:articleTitleHeparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells.lld:pubmed
pubmed-article:8609052pubmed:affiliationDepartment of Biochemistry, Kyushu University School of Medicine.lld:pubmed
pubmed-article:8609052pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8609052pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8609052pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8609052lld:pubmed